Publications by authors named "Sin Ting Chiu"
Article Synopsis
- This study investigated the use of MR-guided radiotherapy (MRgRT) for prostate cancer patients who had undergone surgery, focusing on its clinical outcomes and patient tolerability.
- A total of 30 patients received adaptive MRgRT and were monitored for progression-free survival (PFS) and adverse events over an average follow-up period of around 32 months.
- The results indicated high PFS rates (96.4% at 2 years, 78.8% at 3 years) and low rates of significant side effects, suggesting MRgRT is effective and well-tolerated in this patient group.
Purpose: Diffusion-weighted imaging (DWI) holds promise for image-guided radiotherapy (MRgRT) in prostate cancer. However, challenges persist due to image distortion, artifacts, and apparent diffusion coefficient (ADC) reproducibility issues. This study aimed to assess DWI image quality and ADC reproducibility on both a 1.
View Article and Find Full Text PDFArticle Synopsis
- - This study explored the use of adaptive MR-guided stereotactic body radiation therapy (MRgSBRT) with a rectal spacer in treating localized prostate cancer, focusing on 1-year clinical outcomes from 34 patients.
- - Results indicated significant improvements in target coverage and reduced rectal toxicity in patients using the spacer compared to those who did not, with most side effects being mild and manageable.
- - The findings suggest that MRgSBRT combined with a rectal spacer is well-tolerated, as evidenced by stable patient-reported bowel health and low gastroinestinal side effects over a 1-year follow-up.
Background: Conventionally fractionated whole-pelvic nodal radiotherapy (WPRT) improves clinical outcome compared to prostate-only RT in high-risk prostate cancer (HR-PC). MR-guided stereotactic body radiotherapy (MRgSBRT) with concomitant WPRT represents a novel radiotherapy (RT) paradigm for HR-PC, potentially improving online image guidance and clinical outcomes. This study aims to report the preliminary clinical experiences and treatment outcome of 1.
View Article and Find Full Text PDFPurpose: To analyze and characterize the online plan adaptation of 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer (PC).
Methods: PC patients (n = 107) who received adaptive 1.
Background: Magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) offers the potential for achieving better prostate cancer (PC) treatment outcomes. This study reports the preliminary clinical results of 1.5T MRgSBRT in localized PC, based on both clinician-reported outcome measurement (CROM) and patient-reported outcome measurement (PROM).
View Article and Find Full Text PDF